Medicines Development for Global Health
http://www.medicinesdevelopment.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Medicines Development for Global Health
Deal Watch: Celgene CVR From BMS Buyout Falls Through
Another victim of the COVID-pandemic, Celgene's $9-per-share contingent value right tied to BMS obtaining approval of three drugs goes unrealized due to FDA travel restrictions slowing down site inspections. Clene goes public, United Therapeutics buys PRV from Y-mAbs.
Company Information
- Industry
- Academic and Research Institutions
- Other Names / Subsidiaries
-
- Medicines Development for Global Health (MDGH)
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Medicines Development for Global Health
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice